Accessibility Menu
 
Arrow-Thin-Down
S&P 500
6,591.90
+0.5%
+35.53
Arrow-Thin-Down
DJI
46,429.49
+0.7%
+305.43
Arrow-Thin-Down
NASDAQ
21,929.83
+0.8%
+167.93
Arrow-Thin-Down
Bitcoin
$70,769.00
+0.4%
+$297.44
Arrow-Thin-Down
AMZN
$211.71
+2.2%
+$4.47
Arrow-Thin-Down
GOOG
$289.43
+0.1%
+$0.23
Arrow-Thin-Down
META
$594.67
+0.3%
+$1.75
Arrow-Thin-Down
MSFT
$370.86
-0.5%
-$1.88
Arrow-Thin-Down
NVDA
$178.68
+2.0%
+$3.48
Arrow-Thin-Down
TSLA
$385.67
+0.7%
+$2.64
Most Active StocksDaily Stock GainersDaily Stock Losers

Ask a Fool: Is Gilead Sciences, Inc. a Sell?

Can Gilead's big run in 2013 be replicated in 2014?

By Dave Williamson – Jan 11, 2014 at 8:05AM EST

In this video, as part of The Motley Fool's "Ask a Fool" series, health-care analyst David Williamson takes a question from a Fool reader, who asks:

Gilead Sciences (GILD +0.03%) seems to be on a down trend. Is there any specific reason, or should I just hold firm?

 

Read Next

About the Author

Dave Williamson
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
XMFGreenwave4
X@motleydavid

Stocks Mentioned

Gilead Sciences Stock Quote
Gilead Sciences
NASDAQ: GILD
$138.26
(+0.11%)+$0.15
AbbVie Stock Quote
AbbVie
NYSE: ABBV
$207.18
(+0.96%)+$1.98

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services